A Long-term Follow-up of Adult Kidney and Liver Allograft Recipients Previously Enrolled Into a Tacrolimus (Advagraf) Trial. A Multicentre Non-interventional Post Authorization Study (PAS)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 19 Oct 2017
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection; Renal transplant rejection
- Focus Therapeutic Use
- Acronyms ADDRESS
- Sponsors Astellas Pharma
- 13 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 27 Sep 2017 Interim results (3-year) of the Diamond Study, presented at the 18th Congress of the European Society for Organ Transplantation.
- 26 Jul 2017 Planned End Date changed from 1 Nov 2018 to 1 Jan 2018.